Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.

Background: Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are currently recommended by the National Comprehensive Cancer Network (NCCN) guidelines and the European Society for Medical Oncology (ESMO) guidelines as the first-line (1 L) treatment for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced/metastatic breast cancer (HR+/HER2- LABC/mBC). Although there are many treatment options, there is no clear standard of care for patients following 1 L CDK4/6i. Understanding the real-world effectiveness of subsequent therapies may help to identify an unmet need in this patient population.

Evaluation of different models of general practitioners working in or alongside emergency departments: a mixed-methods realist evaluation.

Background: Emergency healthcare services are under intense pressure to meet increasing patient demands. Many patients presenting to emergency departments could be managed by general practitioners in general practitioner-emergency department service models.

Objectives: To evaluate the effectiveness, safety, patient experience and system implications of the different general practitioner-emergency department models.

Programme theories to describe how different general practitioner service models work in different contexts in or alongside emergency departments (GP-ED): realist evaluation.

Background: Addressing increasing patient demand and improving ED patient flow is a key ambition for NHS England. Delivering general practitioner (GP) services in or alongside EDs (GP-ED) was advocated in 2017 for this reason, supported by £100 million (US$130 million) of capital funding. Current evidence shows no overall improvement in addressing demand and reducing waiting times, but considerable variation in how different service models operate, subject to local context.

Genetic study for seed germination and shattering in in response to different seed treatments.

Spreng is a promising emerging oilseed crop, with its seed oil accounting for approximately 50% of the seed weight. oil contains a significant amount of vernolic acid, comprising two-thirds of its composition, which boasts various industrial applications, including acting as a stabilizer-plasticizer and natural dye. However, this species was known to have a high degree of seed-shattering and a low germination rate, which act as two important barriers to large-scale production and exploitation.

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.

Introduction: Activating RAS gene mutations occur in approximately 55% of patients with metastatic colorectal cancer (mCRC) and are associated with poorer clinical outcomes due to epidermal growth factor receptor (EGFR) blockade resistance. Combined EGFR and mitogen-activated protein kinase (MEK) inhibition may extend response to EGFR inhibition and overcome acquired resistance. This phase Ib/II dose escalation trial evaluated the safety and activity of dual inhibition with binimetinib (MEK1/2 inhibitor) and panitumumab (EGFR inhibitor [EGFRi]) in patients with RAS mutant or BRAF wild type (WT)/RAS WT mCRC.

Understanding how shared decision-making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: A realist review.

Background: Patients with advanced incurable cancer face difficult decisions about palliative treatment options towards their end of life. However, they are often not provided with the appropriate information and support that is needed to make informed decisions. This review aimed to identify contexts and mechanisms associated with communication tools, patient decision-aids and shared decision-making (SDM) approaches that influence patient outcomes.

COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF.

What Is This Summary About?: Here, we summarize the 5-year results from part 1 of the COLUMBUS clinical study, which looked at the combination treatment of encorafenib plus binimetinib in people with a specific type of skin cancer called melanoma. Encorafenib (BRAFTOVI) and binimetinib (MEKTOVI) are medicines used to treat a type of melanoma that has a change in the gene, called advanced or metastatic BRAF V600-mutant melanoma. Participants with advanced or metastatic BRAF V600-mutant melanoma took either encorafenib plus binimetinib together (COMBO group), compared with encorafenib alone (ENCO group) or vemurafenib (ZELBORAF) alone (VEMU group).

Evaluating a Telephone and Home Blood Pressure Monitoring Intervention to Improve Blood Pressure Control and Self-Care Behaviors in Adults with Low-Socioeconomic Status.

Hypertension (HTN) affects nearly 75 million in the United States, and percentages increase with low socioeconomic status (SES) due to poor access to, and quality of, care, and poor self-care behaviors. Federally Qualified Health Centers (FQHCs) employ evidence-based strategies, such as telehealth interventions, to improve blood pressure (BP) control in under-resourced communities, yet a southeastern FQHC could achieve a BP control rate of only 27.6%, well below the Health People 2020 goal of 61.

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.

Background: WNT974 is a small molecule inhibitor of Wnt signaling that specifically inhibits porcupine O-acyltransferase. This phase Ib dose--escalation study evaluated the maximum tolerated dose of WNT974 in combination with encorafenib and cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer with RNF43 mutations or RSPO fusions.

Patients And Methods: Patients received once-daily encorafenib and weekly cetuximab, in addition to once-daily WNT974, in sequential dosing cohorts.

Breed predilections and prognosis for subungual squamous cell carcinoma in dogs.

Objective: To better document the prevalence, breed predilections, and clinical behavior of subungual squamous cell carcinomas in dogs.

Procedure: Retrospective analysis of records from 278 812 canine biopsy submissions including 1518 subungual squamous cell carcinomas from dogs in Canada between the years 2003 and 2021.

Results: In agreement with previous studies, giant schnauzers [odds ratio (OR): 56.

Detection of numerous phycotoxins in young bull sharks (Carcharhinus leucas) collected from an estuary of national significance.

Florida's Indian River Lagoon (IRL) has experienced large-scale, frequent blooms of toxic harmful algae in recent decades. Sentinel, or indicator, species can provide an integrated picture of contaminants in the environment and may be useful to understanding phycotoxin prevalence in the IRL. This study evaluated the presence of phycotoxins in the IRL ecosystem by using the bull shark (Carcharhinus leucas) as a sentinel species.

Implementing public involvement throughout the research process-Experience and learning from the GPs in EDs study.

Background: Public involvement in health services research is encouraged. Descriptions of public involvement across the whole research cycle of a major study are uncommon and its effects on research conduct are poorly understood.

Aim: This study aimed to describe how we implemented public involvement, reflect on process and effects in a large-scale multi-site research study and present learning for future involvement practice.

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With V600-Mutant Melanoma.

Purpose: Combination treatment with BRAF and MEK inhibitors has demonstrated benefits on progression-free survival (PFS) and overall survival (OS) and is a standard of care for the treatment of advanced V600-mutant melanoma. Here, we report the 5-year update from the COLUMBUS trial (ClinicalTrials.gov identifier: NCT01909453).

The Behavioural Impact on Cats during a Transition from a Clay-Based Litter to a Plant-Based Litter.

Current guidelines recommend transitioning cats from one litter product to another over 6 days to minimize stress. The study objective was therefore to test these guidelines using 16 adult domestic cats (2 cohorts of 8) by observing behavioural changes associated with elimination throughout the litter transition. Cats were transitioned from a clay-based litter (CLAY) to a plant-based litter product (PLANT) over 6 days (period 1) via an incremental replacement of CLAY with PLANT.

The effectiveness of primary care streaming in emergency departments on decision-making and patient flow and safety - A realist evaluation.

Unlabelled: Primary care streaming was implemented in UK Emergency Departments (EDs) to manage an increasing demand for urgent care. We aimed to explore its effectiveness in EDs with different primary care models and identify contexts and mechanisms that influenced outcomes: streaming patients to the most appropriate clinician or service, ED flow and patient safety.

Method: We observed streaming and interviewed ED and primary care staff during case study visits to 10 EDs in England.

In pursuit of a better broiler: tibial morphology, breaking strength, and ash content in conventional and slower-growing strains of broiler chickens.

This study was conducted to determine the differences in bone traits in 14 strains of broiler chickens differing in growth rate. The strains encompassed 2 conventional (CONV; ADG >60 g/d) and 12 slower-growing (SG) strains classified as FAST (ADG = 53-55 g/d), MOD (ADG = 50-51 g/d), and SLOW (ADG <50 g/d), with 4 strains represented in each SG category. A total of 7,216 mixed-sex birds were equally allocated into 164 pens (44 birds/pen; 30 kg/m) in a randomized incomplete block design, with each strain represented in 8 to 12 pens over 2-3 trials.

In pursuit of a better broiler: walking ability and incidence of contact dermatitis in conventional and slower growing strains of broiler chickens.

In this study, the mobility, incidence, and severity of contact dermatitis and litter moisture content were assessed in 14 strains of broiler chickens differing in growth rate. The strains encompassed 2 conventional (CONV; ADG > 60 g/d) and 12 slower growing (SG) strains categorized as FAST (ADG = 53-55 g/d), MOD (ADG = 50-51 g/d), and SLOW (ADG < 50 g/d), with 4 strains in each category. A total of 7,216 mixed-sex birds were equally allocated into 164 pens (44 birds/pen; 30 kg/m) in a randomized incomplete block design, with each strain represented in 8 to 12 pens over 2-3 trials.

Patients' experiences of attending emergency departments where primary care services are located: qualitative findings from patient and clinician interviews from a realist evaluation.

Background: Patient experience is an important outcome and indicator of healthcare quality, and patient reported experiences are key to improving quality of care. While patient experience in emergency departments (EDs) has been reported in research, there is limited evidence about patients' specific experiences with primary care services located in or alongside EDs. We aim to identify theories about patient experience and acceptability of being streamed to a primary care clinician in an ED.

Examining science communication on Reddit: From an "Assembled" to a "Disassembling" approach.

This study examines science communication within Ask Me Anything sessions hosted by US National Oceanic and Atmospheric Administration scientists on Reddit. In addition to considering a unique social media platform, our work makes an important contribution in revealing the limitations of a traditional approach to studying science communication and modeling an alternative. First, using an "assembled" approach, we qualitatively explore themes in National Oceanic and Atmospheric Administration scientists' posts and consider how they reflect the goals of "deficit" and "dialogue" models.

In pursuit of a better broiler: a comparison of the inactivity, behavior, and enrichment use of fast- and slower growing broiler chickens.

Selection for rapid growth has produced heavier, more efficient broiler chickens, but has also introduced health and welfare issues, which may cause or be caused by inactivity. Rapid growth may also limit the performance of motivated behaviors, whereas the provision of enrichment may increase these behaviors and general activity. This study aimed to evaluate the inactivity, behavior patterns, and enrichment use of 2 fast- (CONV) and 12 slower growing broiler strains (categorized as fastest [FAST], moderate [MOD], and slowest slow [SLOW]), based on their growth rates; 4 strains/category].

In pursuit of a better broiler: carcass traits and muscle myopathies in conventional and slower-growing strains of broiler chickens.

Selection for accelerated growth rate and high breast yield in broiler chickens have been associated with an increase in myopathies, including wooden breast (WB) and white striping (WS). To investigate effects of growth rate on carcass traits and incidence of myopathies, 14 strains were evaluated, encompassing 2 conventional (CONV; strains B and C: ADG > 60 g/d) and 12 slower-growing (SL) strains. The latter were categorized based on growth rate: FAST (strains F, G, I and M; ADG=53-55 g/d), MOD (strains E, H, O and S; ADG=50-51 g/d), and SLOW (strains D, J, K and N; ADG<50 g/d).

Identifying safe care processes when GPs work in or alongside emergency departments: a realist evaluation.

Background: Increasing pressure on emergency services has led to the development of different models of care delivery including GPs working in or alongside emergency departments (EDs), but with a lack of evidence for patient safety outcomes.

Aim: This study aimed to explore how care processes work and how patient safety incidents associated with GPs working in ED settings may be mitigated.

Design And Setting: Realist methodology with a purposive sample of 13 EDs in England and Wales with different GP service models.